4,856 Shares in Plexus Corp. (NASDAQ:PLXS) Purchased by Bridgewater Associates LP

Bridgewater Associates LP purchased a new position in shares of Plexus Corp. (NASDAQ:PLXS) during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 4,856 shares of the technology company’s stock, valued at approximately $664,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. American Century Companies Inc. increased its holdings in Plexus by 204.3% during the second quarter. American Century Companies Inc. now owns 158,032 shares of the technology company’s stock worth $16,306,000 after buying an additional 106,103 shares during the last quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. increased its stake in shares of Plexus by 8.8% during the 2nd quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 1,079,340 shares of the technology company’s stock worth $111,366,000 after purchasing an additional 87,574 shares during the last quarter. Assenagon Asset Management S.A. raised its holdings in shares of Plexus by 158.0% in the 3rd quarter. Assenagon Asset Management S.A. now owns 82,575 shares of the technology company’s stock valued at $11,289,000 after purchasing an additional 50,564 shares during the period. Algert Global LLC lifted its stake in Plexus by 1,546.5% in the 3rd quarter. Algert Global LLC now owns 45,790 shares of the technology company’s stock valued at $6,260,000 after purchasing an additional 43,009 shares during the last quarter. Finally, Speece Thorson Capital Group Inc. grew its holdings in Plexus by 197.1% during the second quarter. Speece Thorson Capital Group Inc. now owns 50,498 shares of the technology company’s stock worth $5,210,000 after purchasing an additional 33,501 shares during the period. Institutional investors own 94.45% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have issued reports on PLXS. Needham & Company LLC upped their price objective on Plexus from $144.00 to $162.00 and gave the company a “buy” rating in a research note on Friday, October 25th. StockNews.com upgraded Plexus from a “hold” rating to a “buy” rating in a research note on Monday, November 18th. KeyCorp initiated coverage on shares of Plexus in a research report on Tuesday, October 22nd. They set a “sector weight” rating for the company. Finally, Benchmark increased their price objective on shares of Plexus from $150.00 to $165.00 and gave the company a “buy” rating in a research report on Monday, October 28th. Three research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $133.50.

Insider Activity

In other Plexus news, CFO Patrick John Jermain sold 5,045 shares of the stock in a transaction dated Monday, October 28th. The stock was sold at an average price of $143.13, for a total value of $722,090.85. Following the completion of the transaction, the chief financial officer now directly owns 24,602 shares in the company, valued at approximately $3,521,284.26. This trade represents a 17.02 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Michael J. Running sold 539 shares of the business’s stock in a transaction dated Wednesday, November 20th. The stock was sold at an average price of $155.87, for a total value of $84,013.93. Following the sale, the insider now owns 1,030 shares in the company, valued at approximately $160,546.10. This trade represents a 34.35 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 32,591 shares of company stock worth $5,143,375. Insiders own 2.39% of the company’s stock.

Plexus Price Performance

Shares of PLXS stock opened at $166.45 on Tuesday. The business has a fifty day simple moving average of $147.10 and a 200 day simple moving average of $126.65. The company has a market cap of $4.51 billion, a P/E ratio of 41.51 and a beta of 0.87. The company has a quick ratio of 0.71, a current ratio of 1.51 and a debt-to-equity ratio of 0.07. Plexus Corp. has a twelve month low of $90.18 and a twelve month high of $169.41.

Plexus (NASDAQ:PLXS) last posted its earnings results on Wednesday, October 23rd. The technology company reported $1.85 EPS for the quarter, topping analysts’ consensus estimates of $1.55 by $0.30. The firm had revenue of $1.05 billion during the quarter, compared to analysts’ expectations of $1.01 billion. Plexus had a net margin of 2.82% and a return on equity of 9.51%. The business’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.44 earnings per share. On average, sell-side analysts forecast that Plexus Corp. will post 6.14 EPS for the current fiscal year.

Plexus Company Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.